Literature DB >> 17884023

Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.

Justin D Boyd1, Haeman Jang, Kennie R Shepherd, Ciaran Faherty, Sally Slack, Yun Jiao, Richard J Smeyne.   

Abstract

Parkinson's disease (PD) is a neurodegenerative disease whose hallmark pathological features include a selective loss of dopaminergic neurons in the midbrain. Recent studies have described the activation of a stress-induced signal cascade, c-Jun N-terminal kinase (JNK)-mediated activation of c-Jun, and an increase in the expression of a downstream effector, cyclooxygenase 2 (COX-2), in postmortem PD brains. The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which induces selective neuronal loss in the midbrain similar to that seen in PD, also induces JNK-mediated activation of c-Jun and generates a COX-2 response in C57BL/6J mice. However, mice exhibit a strain-dependent susceptibility to MPTP. Identifying the point(s) of molecular divergence in the MPTP-induced response may provide insight into the cause of PD or a means to identify susceptibility to PD in humans. Here we examined JNK signaling and COX-2 induction in two strains of mice, the MPTP-sensitive C57BL/6J and the MPTP-resistant Swiss Webster (SW). We show that C57BL/6J and SW strains differ in JNK and c-Jun activation in response to MPTP. In addition, the MPTP-induced COX-2 response occurs exclusively in C57BL/6J mice. Furthermore, strain-specific responses to MPTP are not due to differences in MPP(+) levels and are not secondary to cell death. These results provide evidence toward a mechanism of strain-dependent sensitivity to MPTP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17884023      PMCID: PMC2084084          DOI: 10.1016/j.brainres.2007.07.067

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  49 in total

1.  Time-course and dose-response study on the effects of chronic L-DOPA administration on striatal dopamine levels and dopamine transporter following MPTP toxicity.

Authors:  F Fornai; G Battaglia; M Gesi; F S Giorgi; F Orzi; F Nicoletti; S Ruggieri
Journal:  Brain Res       Date:  2000-12-22       Impact factor: 3.252

Review 2.  The last decade in Parkinson's disease research. Basic sciences.

Authors:  S Przedborski; M Vila
Journal:  Adv Neurol       Date:  2001

3.  Identification of a glutathione-S-transferase effector domain for inhibition of jun kinase, by molecular dynamics.

Authors:  R Monaco; F K Friedman; M J Hyde; J M Chen; S Manolatus; V Adler; Z Ronai; W Koslosky; M R Pincus
Journal:  J Protein Chem       Date:  1999-11

4.  Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus.

Authors:  T Wang; P Arifoglu; Z Ronai; K D Tew
Journal:  J Biol Chem       Date:  2001-03-09       Impact factor: 5.157

5.  In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.

Authors:  R G Staal; K A Hogan; C L Liang; D C German; P K Sonsalla
Journal:  J Pharmacol Exp Ther       Date:  2000-05       Impact factor: 4.030

6.  MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences.

Authors:  M Sedelis; K Hofele; G W Auburger; S Morgan; J P Huston; R K Schwarting
Journal:  Behav Genet       Date:  2000-05       Impact factor: 2.805

7.  GSTpi expression mediates dopaminergic neuron sensitivity in experimental parkinsonism.

Authors:  Michelle Smeyne; Justin Boyd; Kennie Raviie Shepherd; Yun Jiao; Brooks Barnes Pond; Matthew Hatler; Roland Wolf; Colin Henderson; Richard Jay Smeyne
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

8.  Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases.

Authors:  Z Yin; V N Ivanov; H Habelhah; K Tew; Z Ronai
Journal:  Cancer Res       Date:  2000-08-01       Impact factor: 12.701

9.  Seizure-induced neuronal death is associated with induction of c-Jun N-terminal kinase and is dependent on genetic background.

Authors:  P E Schauwecker
Journal:  Brain Res       Date:  2000-11-24       Impact factor: 3.252

10.  Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease.

Authors:  X G Xia; T Harding; M Weller; A Bieneman; J B Uney; J B Schulz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

View more
  20 in total

1.  Exercise protects against MPTP-induced neurotoxicity in mice.

Authors:  Kimberly M Gerecke; Yun Jiao; Amar Pani; Vishwajeeth Pagala; Richard J Smeyne
Journal:  Brain Res       Date:  2010-01-29       Impact factor: 3.252

2.  Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice.

Authors:  Haeman Jang; David Boltz; Jennifer McClaren; Amar K Pani; Michelle Smeyne; Ane Korff; Robert Webster; Richard Jay Smeyne
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

3.  A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6J mouse.

Authors:  Z C Baquet; D Williams; J Brody; R J Smeyne
Journal:  Neuroscience       Date:  2009-04-17       Impact factor: 3.590

4.  Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum.

Authors:  R Pattarini; Y Rong; C Qu; J I Morgan
Journal:  Neuroscience       Date:  2008-07-08       Impact factor: 3.590

5.  Seizure resistance without parkinsonism in aged mice after tau reduction.

Authors:  Zhiyong Li; Alicia M Hall; Mark Kelinske; Erik D Roberson
Journal:  Neurobiol Aging       Date:  2014-05-09       Impact factor: 4.673

6.  The effect of docosahexaenoic Acid on visual evoked potentials in a mouse model of Parkinson's disease: the role of cyclooxygenase-2 and nuclear factor kappa-B.

Authors:  Ozlem Ozsoy; Gamze Tanriover; Narin Derin; Nimet Uysal; Necdet Demir; Burcu Gemici; Ceren Kencebay; Piraye Yargicoglu; Aysel Agar; Mutay Aslan
Journal:  Neurotox Res       Date:  2011-01-14       Impact factor: 3.911

7.  Admixing of MPTP-Resistant and Susceptible Mice Strains Augments Nigrostriatal Neuronal Correlates to Resist MPTP-Induced Neurodegeneration.

Authors:  D J Vidyadhara; H Yarreiphang; T R Raju; Phalguni Anand Alladi
Journal:  Mol Neurobiol       Date:  2016-10-04       Impact factor: 5.590

8.  Gene-environment interaction models to unmask susceptibility mechanisms in Parkinson's disease.

Authors:  Vivian P Chou; Novie Ko; Theodore R Holman; Amy B Manning-Boğ
Journal:  J Vis Exp       Date:  2014-01-07       Impact factor: 1.355

9.  Parkin-knockout mice did not display increased vulnerability to intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Authors:  Aderbal S Aguiar; Fabrine S M Tristão; Majid Amar; Caroline Chevarin; Laurence Lanfumey; Raymond Mongeau; Olga Corti; Rui D Prediger; Rita Raisman-Vozari
Journal:  Neurotox Res       Date:  2013-04-16       Impact factor: 3.911

10.  The effects of piroxicam in the attenuation of MPP+/MPTP toxicity in vitro and in vivo.

Authors:  Y Soliman; T Jackson; E Mazzio; K F A Soliman
Journal:  Neurochem Res       Date:  2008-07-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.